Examkin

Question

Difficulty: Very hardPreventive Care and Immunizations

A 15-month-old boy is brought to the clinic for a routine well-child visit. He has not been evaluated by a physician since his 6-month visit because his family relocated. At 10 months of age, he was hospitalized for 5 days with a prolonged high fever, bilateral nonexudative conjunctivitis, mucosal changes, and unilateral cervical lymphadenopathy. Echocardiography at that time showed normal coronary arteries. He was treated successfully with high-dose aspirin and a single infusion of intravenous immunoglobulin (IVIG). He currently takes no medications. Developmentally, he walks independently and uses three specific words. He lives with his parents and a 4-year-old sister who is receiving maintenance chemotherapy for acute lymphoblastic leukemia. His immunization records indicate he received all recommended vaccinations at 2, 4, and 6 months of age. Which of the following is the most appropriate next step in management?

  1. Administer the appropriate inactivated vaccines, defer live-attenuated vaccines due to exogenous antibody interference, and reassure the parents regarding his development.Answer
  2. B
    Administer the appropriate inactivated vaccines, defer live-attenuated vaccines to prevent viral transmission to his sister, and reassure the parents regarding his development.
  3. C
    Administer all missing inactivated and live-attenuated vaccines to provide indirect protection for his sister, and reassure the parents regarding his development.
  4. D
    Administer the appropriate inactivated vaccines, defer live-attenuated vaccines due to exogenous antibody interference, and refer the patient for developmental evaluation.
  5. E
    Administer all missing inactivated and live-attenuated vaccines to complete the catch-up schedule, and refer the patient for developmental evaluation.

Answer

Administer the appropriate inactivated vaccines, defer live-attenuated vaccines due to exogenous antibody interference, and reassure the parents regarding his development.
This patient requires a catch-up well-child visit. His history is diagnostic of Kawasaki disease treated with IVIG at 10 months of age. While he is due for 12-15 month immunizations, high-dose IVIG contains pooled IgG that can neutralize live vaccine viruses. Therefore, live-attenuated vaccines (MMR, varicella) must be deferred for 11 months following high-dose IVIG (until the child is 21 months old). Inactivated vaccines (e.g., Hib, pneumococcal, DTaP) are unaffected and should be administered. Furthermore, his developmental milestones (walking independently, 3 words) are perfectly normal for a 15-month-old, requiring only reassurance.

Step-by-Step Solution

1
Diagnose the past medical illness.
The history of prolonged fever, conjunctivitis, mucosal changes, and lymphadenopathy treated with aspirin and IVIG at 10 months is diagnostic of Kawasaki disease.
Identifying the disease confirms the indication and dosage for the IVIG therapy (typically high-dose at 2 g/kg), which impacts future medical management.
2
Evaluate the impact of previous treatment on the current immunization schedule.
High-dose IVIG contains pooled IgG that neutralizes live vaccine viruses. Live-attenuated vaccines (MMR, varicella) must be deferred for 11 months post-infusion.
Administering live vaccines too soon after IVIG results in a failure to mount an adequate immune response. The patient is 15 months old (5 months post-IVIG), so live vaccines must be deferred until he is 21 months old.
3
Determine the impact of the sibling's health status on the patient's vaccines.
The sister's chemotherapy is NOT a contraindication for the patient's live vaccines.
Household contacts of immunocompromised individuals should receive all routine vaccinations, including live vaccines, to maximize indirect protection (herd immunity). The deferral is entirely due to the IVIG.
4
Assess the patient's developmental milestones.
Walking independently and using three words are completely normal milestones for a 15-month-old infant.
Properly identifying normal development prevents unnecessary referrals for early intervention.

Key Concept

Live-attenuated vaccines (such as MMR and varicella) must be deferred for up to 11 months following high-dose IVIG therapy to prevent exogenous antibody interference. Additionally, immunocompromised household contacts are an indication, not a contraindication, for vaccinating healthy children.
Estimated Time:1m 30s
Rate this question

Topics

Preventive Care and Immunizations

More questions from this topic